Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants

Meningococcal disease

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of Age Safety of MenACWY-CRM Vaccination in Adolescents Safety Surveillance of MenACWY-CRM Vaccine in Children Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines 36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds Assessment of Antibody Persistence at Eighteen Months After the Completion of the Vaccination Course in Study V72P10 Safety, Tolerability and Immunogenicity of Three Doses of Novartis Meningococcal B Vaccine When Administered to Healthy At-risk Adults Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines